This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aaberge, I S Articles by Løvik, M Search for Related Content PubMed PubMed Citation Articles by Aaberge, I S Articles by Løvik, M

 Previous Article  |  Next Article 

Infect Immun. 1992 October; 60(10): 4146-4153

SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.

Department of Immunology, National Institute of Public Health, Oslo, Norway.

ABSTRACT

Seventy-eight severe combined immunodeficiency (SCID) mice were administered intraperitoneally 1 x 10(7) to 9 x 10(7) human peripheral blood mononuclear cells (PBL) in five experiments. Human immunoglobulin G (IgG) was detected in 70 to 88% of these SCID-PBL-Hu mice after cell transplantation, and all four subclasses were present. The total concentration of human IgG varied from less than 1 to 10.2 g/liter. The SCID-PBL-Hu mice with high concentrations of human IgG regularly had mono- or oligoclonal human IgG bands in serum, as demonstrated by agarose gel electrophoresis. Of the SCID-PBL-Hu mice that were immunized with a 23-valent pneumococcal polysaccharide vaccine, 63 to 78% developed a significant human IgG antipneumococcal antibody response, whereas only very low levels of human IgM and no human IgA antipneumococcal antibodies could be detected. Twelve to twenty-two percent of the SCID-PBL-Hu mice showed signs of leakiness; these mice developed a significant mouse IgM antipneumococcal antibody response and no human antibodies. SCID-PBL-Hu mice were challenged intraperitoneally with 10 50% lethal doses of Streptococcus pneumoniae serotype 4 to study the protective effect of immunization with pneumococcal vaccine. The immunized SCID-PBL-Hu mice showed less bacteremia than did all control groups, and survival was 45 to 60%. None of the unimmunized SCID-PBL-Hu mice survived.

This article has been cited by other articles:

• Flobakk, M., Rasmussen, I. B., Lunde, E., Frigstad, T., Berntzen, G., Michaelsen, T. E., Bogen, B., Sandlie, I. (2008). Processing of an Antigenic Sequence from IgG Constant Domains for Presentation by MHC Class II. J. Immunol. 181: 7062-7072 [Abstract] [Full Text]  
• Bakke, H., Lie, K., Haugen, I. L., Korsvold, G. E., Hoiby, E. A., Nass, L. M., Holst, J., Aaberge, I. S., Oftung, F., Haneberg, B. (2001). Meningococcal Outer Membrane Vesicle Vaccine Given Intranasally Can Induce Immunological Memory and Booster Responses without Evidence of Tolerance. Infect. Immun. 69: 5010-5015 [Abstract] [Full Text]  
• Hvalbye, B. K. R., Aaberge, I. S., Lovik, M., Haneberg, B. (1999). Intranasal Immunization with Heat-Inactivated Streptococcus pneumoniae Protects Mice against Systemic Pneumococcal Infection. Infect. Immun. 67: 4320-4325 [Abstract] [Full Text]  
• Delhem, N., Hadida, F., Gorochov, G., Carpentier, F., de Cavel, J.-P., Andreani, J.-F., Autran, B., Cesbron, J.-Y. (1998). Primary Th1 Cell Immunization Against HIVgp160 in SCID-hu Mice Coengrafted with Peripheral Blood Lymphocytes and Skin. J. Immunol. 161: 2060-2069 [Abstract] [Full Text]  
• Lovik, M. (1995). The SCID mouse as a model in immunotoxicology. Hum Exp Toxicol 14: 126-131